Freestone Capital Holdings, LLC Dexcom Inc Transaction History

Freestone Capital Holdings, LLC

$2.87 Billion
Q4 2024

A detailed history of Freestone Capital Holdings, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 22,780 shares of DXCM stock, worth $1.56 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

22,780

Previous 19,143 19.0%

Holding current value

$1.56 Million

Previous $1.28 Million 38.14%

% of portfolio

0.06%

Previous 0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$65.68 - $81.01 $238,878 - $294,633	3,637 Added 19.0%	22,780 $1.77 Million
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $257,536 - $467,025	4,024 Added 26.62%	19,143 $1.28 Million
Q2 2024 Nov 22, 2024	BUY	$110.31 - $140.45 $97,514 - $124,157	884 Added 6.21%	15,119 $1.71 Million
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $97,514 - $124,157	884 Added 6.21%	15,119 $1.71 Million
Q1 2024 Nov 22, 2024	SELL	$114.22 - $140.1 $560,591 - $687,610	-4,908 Reduced 25.64%	14,235 $1.97 Million
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $71,958 - $88,263	630 Added 4.63%	14,235 $1.97 Million
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $32,989 - $54,257	437 Added 3.32%	13,605 $1.69 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $256,889 - $411,721	2,985 Added 29.31%	13,168 $1.23 Million
Q2 2023 Aug 09, 2023	BUY	$112.47 - $130.98 $13,158 - $15,324	117 Added 1.16%	10,183 $1.31 Million
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $10,400 - $12,292	-100 Reduced 0.98%	10,066 $1.17 Million
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $16,571 - $23,920	-195 Reduced 1.88%	10,166 $1.15 Million
Q3 2022 Nov 09, 2022	SELL	$76.35 - $94.18 $47,260 - $58,297	-619 Reduced 5.64%	10,361 $834,000
Q2 2022 Aug 09, 2022	BUY	$67.99 - $132.89 $538,888 - $1.05 Million	7,926 Added 259.53%	10,980 $818,000
Q1 2022 May 12, 2022	BUY	$94.08 - $130.2 $125,596 - $173,816	1,335 Added 77.66%	3,054 $1.56 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $38,571 - $48,357	297 Added 20.89%	1,719 $923,000
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $151,741 - $203,601	1,422 New	1,422 $778,000
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $9,750 - $12,045	-115 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $4,368 - $5,852	56 Added 94.92%	115 $42.5 Million
Q3 2020 Nov 06, 2020	BUY	$95.51 - $112.95 $5,635 - $6,664	59 New	59 $6,000

Others Institutions Holding DXCM

# of Institutions

1,084

Shares Held

353M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.

Account

Freestone Capital Holdings, LLC Dexcom Inc Transaction History